The Federal Government has confirmed the arrival of a new HIV prevention injection, Lenacapavir, marking a major milestone in Nigeria’s fight against the epidemic.
Dr. Adebobola Bashorun, National Coordinator of the HIV, Viral Hepatitis and STDs Control Programme, described the development as “a clear demonstration of Nigeria’s resolve to scale up innovative solutions and strengthen the fight against HIV.”
According to Bashorun, the rollout will be carefully managed. “NASCP, in collaboration with partners and stakeholders, will ensure the safe introduction, strategic deployment, and effective integration of Lenacapavir into the national HIV prevention options,” he said.
Lenacapavir is administered twice a year, offering a more convenient alternative to daily oral preventive medications. Officials say this injectable option could improve adherence and expand access to HIV prevention services, particularly for populations that struggle with daily pills.
“The rollout will support ongoing efforts to increase access to prevention services while reinforcing Nigeria’s broader HIV response,” Bashorun added. He emphasized that equitable access to prevention, testing, treatment, and care remains central to the country’s strategy.
The drug is expected to be available in Nigeria and 119 other low- and middle-income countries at $40 per person annually, following voluntary licensing agreements with generic manufacturers. Health experts say this pricing could make the breakthrough more accessible.
“This milestone, approved by the Coordinating Minister of Health and Social Welfare, Prof. Ali Pate, and supported through the Global Fund, represents a major advancement in the country’s HIV prevention efforts,” the statement concluded.
Discover more from Rootedscope Media
Subscribe to get the latest posts sent to your email.
